SCHEMBL6565012

SCHEMBL6565012

COc1ccc(NC(=O)Nc2ccc(OC(c3ccc(C(F)(F)F)cc3)c3ccccc3Cl)c(C(=O)NC(C)(C)C)c2)cc1OC

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 1/20 0.40
IMPDH1 P20839 1/20 0.40
MAPT P10636 3/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
MCHR1 Q99705 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
PTGS2 P35354 1/20 0.40
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
HPGD P15428 1/20 0.39
PPARA Q07869 1/20 0.39
CTSA P10619 1/20 0.38
HTR2A P28223 2/20 0.38
HTR2C P28335 2/20 0.38
ANO1 Q5XXA6 1/20 0.38
IGF1R P08069 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565693 0.92 SMN1; SMN2 (0.42) IMPDH2IMPDH1MAPTKMT2AMEN1
SCHEMBL6566690 0.91 KMT2A (0.42) IMPDH2IMPDH1MAPTKMT2AMEN1
SCHEMBL6566725 0.90 MAPT (0.43) MAPTKMT2AMEN1MCHR1NR1H4
SCHEMBL6564645 0.90 MEN1 (0.44) MAPTKMT2AMEN1MCHR1PTGS2
SCHEMBL6564637 0.90 IMPDH2 (0.44) IMPDH2IMPDH1MAPTKMT2AMEN1
SCHEMBL6568233 0.87 POLB (0.42) IMPDH2IMPDH1MAPTKMT2AMEN1
SCHEMBL6567587 0.87 IMPDH2 (0.44) IMPDH2IMPDH1MAPTKMT2AMEN1
SCHEMBL6567816 0.86 MTOR (0.45) IMPDH2IMPDH1MAPTKMT2AMEN1
SCHEMBL6566701 0.85 RAB9A (0.44) IMPDH2IMPDH1MAPTKMT2AMEN1
SCHEMBL6567917 0.82 IMPDH2 (0.51) IMPDH2IMPDH1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US claimed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP claimed
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 IMPDH2 4497/4885IMPDH1 4113/4885MAPT 4743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.